Oseltamivir Capsules IP

Oseltamivir Capsules IP Specification

Storage
Cool & dry place

Dosage Form
Capsules

Usage
Hospital

Origin of Medicine
Made in India

Dosage
75 mg

Oseltamivir Capsules IP Trade Information

Minimum Order Quantity
100 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
7-10 Days

Main Export Market(s)
Asia, Australia, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Oseltamivir Capsules IP

neuraminidase inhibitor. It inhibits neuraminidase (influenza virus enzyme) that helps the viruses to enter into uninfected cells of the body to cause or spread influenza infection in the body. This is how it works against the virus to treat influenza (flu).

Reliable Antiviral Solution

Oseltamivir Capsules IP are trusted by hospitals across India for treating and preventing influenza. Manufactured under stringent quality standards, these capsules are designed to inhibit the viral replication of influenza, providing timely relief and recovery. Their efficacy and quality make them a preferred choice for healthcare professionals.

Safe Storage and Administration

Each 75 mg capsule of Oseltamivir should be stored in a cool and dry place to preserve its potency. Hospitals and medical facilities can rely on this formulation for consistent performance and therapeutic results. The capsules are easy to administer, catering to both adult and pediatric patients as directed by medical guidelines.

FAQs of Oseltamivir Capsules IP:

Q: How should Oseltamivir Capsules IP 75 mg be stored?

A: Oseltamivir Capsules should be stored in a cool and dry place to ensure their stability and effectiveness. Avoid exposing the capsules to excessive heat or moisture, and keep them in their original packaging until use.

Q: What is the primary use of Oseltamivir Capsules IP in hospitals?

A: Oseltamivir Capsules are primarily used for the treatment and prevention of influenza infections in hospital settings. They help reduce the severity and duration of flu symptoms when started promptly after onset.

Q: When should Oseltamivir Capsules be administered for best results?

A: It is most effective when administered as soon as possible after the onset of influenza symptoms, ideally within 48 hours. Early treatment optimizes the benefits of the antiviral action and limits the spread of the virus.

Q: Where are these Oseltamivir Capsules IP manufactured and supplied from?

A: These capsules are manufactured in India and distributed by trusted suppliers and traders specializing in hospital-grade pharmaceuticals.

Q: What is the process for using Oseltamivir Capsules in a hospital setting?

A: In hospitals, Oseltamivir is administered under the supervision of healthcare professionals. The dosage and duration are determined based on patient age, weight, and severity of illness, following established clinical protocols.

Q: What benefits do Oseltamivir Capsules IP offer to hospitals and patients?

A: They offer effective viral control, reduce flu-related complications, and potentially decrease the length of hospital stay. Timely use also curtails the spread of influenza within hospital environments.

Tell us about your requirement